Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New phase III data on the efficacy of fesoterodine in OAB

April 20, 2005

SPI-153 enters phase II trial for BPH

April 18, 2005

5-HT2C agonists evaluated as therapeutics for urinary disorders

April 15, 2005

Toray and Takeda to jointly develop compound for frequent urination

April 11, 2005

Recent Roche patents describe therapeutic agents for genitourinary disorders

April 7, 2005

Dong-A PharmTech files IND for new PDE5 inhibitor for erectile dysfunction

April 1, 2005

Keryx finalizes SPA agreement for KRX-101

March 31, 2005

NX-1207 shows promise for BPH

March 29, 2005

PT-141 reported to increase the efficacy of sildenafil in ED

March 24, 2005

The STAR study confirms the greater efficacy of solifenacin in OAB

March 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...